Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia

Khan, Sujoy; Durairaj, Senthilkumar; Phumphukhieo, Punyarat; Holding, Stephen; Allsup, David

doi:10.1080/10428194.2021.1885662

Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia

Khan, Sujoy; Durairaj, Senthilkumar; Phumphukhieo, Punyarat; Holding, Stephen; Allsup, David

Authors

Sujoy Khan

Senthilkumar Durairaj

Punyarat Phumphukhieo

Stephen Holding

Professor David Allsup D.J.Allsup@hull.ac.uk
Professor of Haematology

Citation

Khan, S., Durairaj, S., Phumphukhieo, P., Holding, S., & Allsup, D. (2021). Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia. Leukemia & Lymphoma, 1-8. https://doi.org/10.1080/10428194.2021.1885662

Journal Article Type	Letter
Acceptance Date	Jan 28, 2021
Online Publication Date	Feb 17, 2021
Publication Date	Feb 17, 2021
Deposit Date	Feb 18, 2021
Publicly Available Date	Feb 18, 2022
Journal	Leukemia and Lymphoma
Print ISSN	1042-8194
Electronic ISSN	1029-2403
Publisher	Taylor and Francis
Peer Reviewed	Peer Reviewed
Pages	1-8
DOI	https://doi.org/10.1080/10428194.2021.1885662
Keywords	Cancer Research; Oncology; Hematology
Public URL	https://hull-repository.worktribe.com/output/3726327

Files

Article (109 Kb)
PDF

Copyright Statement
©2021 The authors. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder